No Detail Found!

A randomized control trial to evaluate the efficacy of a single intravitreal bevacizumab injection before cataract surgery in patients with diabetic macular edema.

Author(s)
Ghulamqadir Kazi Ophthalmology, Al-Tibri Medical College, Karachi, Pakistan
Umer Kazi Ophthalmology, Al-Tibri Medical College, Karachi, Pakistan
Umair Qidwai Al-Tibri Medical College & Hospital, Isra University, Karachi Campus, Karachi, Pakistan
Azfar Nafees Al-Tibri Medical College & Hospital, Isra University, Karachi Campus, Karachi, Pakistan
Asif Kazi Al-Tibri Medical College & Hospital, Isra University, Karachi Campus, Karachi, Pakistan
Munawar Hussain Al-Tibri Medical College & Hospital, Isra University, Karachi Campus, Karachi, Pakistan
Abstract
AIMS: To evaluate the efficacy of a single intravitreal Bevacizumab injection before cataract surgery METHODS: Randomised, controlled, open-label, parallel group study of 90 eyes of 90, having diabetic macular edema and lens opacity (of more than grade 3). Change in BCVA at 6 weeks compared with that at baseline. Central macular thickness was compared in both groups pre and post operatively. RESULTS: In Bevacizumab group, 86.7% had BCVA of 6/18 or better and decrease in macular thickness(mean 97 microns), while in control group, only 46.7% had BCVA of 6/18 or better and increased macular thicknes (mean 30 microns) was observed. CONCLUSIONS: Intravitreal Bevacizumab before cataract surgery appears to be beneficial in preventing post- surgical visual loss in eyes with diabetic retinopathy by reducing the chance of macular thickening.
Publication Details
Page(s) 71-75
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 4, Issue: 2, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

63

Views